Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FQFRL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,806
Award facts
- Contract value 100% obligated
- $8,805.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections with a ceiling value of $8,805.91. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of medications and medical supplies to support Defense Health Agency operations and other government healthcare systems. The company's contract awards with DLA demonstrate its capability to deliver a diverse range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic areas. The Zepbound order reflects ongoing federal procurement needs for diabetes and weight management medications within military healthcare programs, leveraging AmerisourceBergen's established distribution infrastructure and vendor relationships.
Quick answers
Who was awarded contract SPE2DB25FQFRL?
SPE2DB25FQFRL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FQFRL worth?
The government has obligated $8,806 on SPE2DB25FQFRL.
Is contract SPE2DB25FQFRL an order under another contract?
Yes. SPE2DB25FQFRL is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQFRL competed?
The extent of competition for SPE2DB25FQFRL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award